NMS Menu

Coordinated by GU Ventures

Contact Us

Interested in Our Work or Seeking Guidance and Support?

Get in touch with New Modality Support or reach out directly to one of the project partners below.

Two people in conversation at New Modality Support

I’m interested in:

Stephanie Mattsson, Director Venture Development, CCRM

Stephanie works in life science venture development and international business. She has more than five years of experience in regenerative medicine and has helped companies and publicly funded initiatives with strategy and business development.

stephanie.mattsson@ccrmnordic.se

ccrmnordic.se

Fredrik Wångsell, PhD, Research Advisor, OligoNova

Fredrik has more than 15 years of industry experience in drug research and development, from early discovery through preclinical evaluation. He works with OligoNova and New Modality Support to prepare research projects for commercialization.

fredrik.wangsell@gu.se

oligonova.org

Carl-Peter Mattsson, Coordinator NMS, Investment Director, GU Ventures

Carl-Peter has more than 25 years of venture capital experience, including direct and fund investments in Sweden and internationally. His work spans life science and other industries, with an emphasis on partnerships and financing strategy.

carl-peter@ventures.gu.se

guventures.com